Biodesix (BDSX) Return on Equity (2020 - 2026)

Biodesix has reported Return on Equity for 7 years, with the latest figure at 0.1% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity fell 7.0% year-over-year to 0.1%; the trailing twelve-month figure through Mar 2026 stood at 0.1% (down 7.0% YoY), and the FY2025 full-year result was 0.04%, down 1.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.1%, down from 0.17% in the prior quarter.
• The five-year high for Return on Equity was 1.37% in Q3 2025, with the low at 0.32% in Q4 2023.
• Historically, Return on Equity has averaged 0.13% across 5 years, with a median of 0.03% in 2024.
• The largest YoY upside for Return on Equity was 138 bps in 2025 against a maximum downside of 102 bps in 2025.
• Biodesix's Return on Equity stood at 0.07% in 2022, then slumped by 390 bps to 0.32% in 2023, then soared by 95 bps to 0.02% in 2024, then jumped by 1069 bps to 0.17% in 2025, then tumbled by 158 bps to 0.1% in 2026.
• The last three Return on Equity figures came in at 0.1% (Q1 2026), 0.17% (Q4 2025), and 1.37% (Q3 2025), per Business Quant data.